Ocular tissue levels of 1.5 percent levofloxacin ophthalmic solution compared to an active comparator [moxifloxacin]
Phase of Trial: Phase IV
Latest Information Update: 04 Feb 2009
At a glance
- Drugs Levofloxacin; Levofloxacin; Moxifloxacin
- Indications Bacterial infections; Ophthalmic infections
- Focus Pharmacokinetics
- Sponsors Santen Incorporated
- 04 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Mar 2008 New trial record.